Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIB4920 in Sjögren's Syndrome
CTR20202047Phase 2Terminated
- Sponsor
- Tigermed
- Start
- Oct 2020
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dazodalibep in Sjögren's syndrome, sponsored by Tigermed. Started Oct 2020; status: terminated.
02
Drugs
dazodalibep
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on CTR20202047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202047.